Nanotechnology pH-Responsive Nanocarrier for Targeted Doxorubicin DeliveryEditor-In-ChiefMarch 9, 2026 Early lab tests suggest the nanocarrier stays stable in water, responds to pH changes and shows anticancer activity in breast…